Chronic low-dose rapamycin treatment fine tunes cardioprotective signalling in ischaemia-reperfused diabetic hearts

Cardiovasc Res. 2020 Nov 1;116(13):2038-2039. doi: 10.1093/cvr/cvaa304.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Animals
  • Diabetes Mellitus, Experimental*
  • Ischemia
  • Mice
  • MicroRNAs*
  • Myocardial Infarction*
  • Sirolimus

Substances

  • MicroRNAs
  • Sirolimus